Effect of lymphangiogenesis and lymphovascular invasion on the survival pattern of breast cancer patients

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 15, 2014, Pages 6287-6293

  Sahoo, Pradyumna Kumar ^a   Jana, Debarshi ^b   Mandal, Palash Kumar ^c   Basak, Samindranath ^a  

^a Saroj Gupta Cancer Centre and Research Institute   (India)

^b INSTITUTE OF POST GRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

^c NORTH BENGAL MEDICAL COLLEGE   (India)

Author keywords

Breast cancer; Lymphovascular invasion; Perineural invasion; Survival

Indexed keywords

ADENOCARCINOMA, MUCINOUS; ADULT; AGED; BREAST NEOPLASMS; CANCER STAGING; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CARCINOMA, MEDULLARY; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; LYMPH VESSEL; LYMPHANGIOGENESIS; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; SECONDARY; SURVIVAL RATE; TUMOR INVASION; VERY ELDERLY; YOUNG ADULT;

ADENOCARCINOMA, MUCINOUS; ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CARCINOMA, MEDULLARY; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHANGIOGENESIS; LYMPHATIC METASTASIS; LYMPHATIC VESSELS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; YOUNG ADULT;

EID: 84906218716     PISSN: 15137368     EISSN: None     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.15.6287     Document Type: Article

References (26)

1. Carter CL, Allen C, Henson DE (1989). Relation of tumour size, lymph node status, and survival in 24,740 BC Cases. Cancer, 63, 181-7.
2. Cooke T, Reeves J, Lanigan A, Stanton P (2001). HER2 as a prognostic and predictive marker for breast cancer. Ann Oncol, 1, 23-8.
3. Das S, Sen S, Mukherjee A, Chakraborty D, Mondal PK (2012). Risk factors of breast cancer among women in eastern India: a tertiary hospital based case control study. Asian Pac J Cancer Prev, 13, 4979-81.
4. Desmedt C, Haibe-Kains B, Wirapati P, et al (2008). Biological process associated with breast cancer clinical outcome depend on the molecular subtypes. Clin Cancer Res, 14, 5158-65.
5. Donegan WL (1997). Tumor-related prognostic factors for breast cancer. CA Cancer J Clin, 47, 28-51.
6. Ferlay J, Shin HR, Bray F, et al (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer, 127, 2893-917.
7. Ferno M (1998). Prognostic factors in breast cancer: a brief review. Anticancer Res, 18, 2167-71.
8. Henson DE, Ries L, Freedman LS, Carriaga M (1991). Relationship among outcome, stage of disease, and histologic grade for 22,616 cases of breast cancer. The basis for a prognostic index. Cancer, 68, 2142-9.
9. Jana D, Das S, Sarkar DK, et al (2012). Role of nuclear factor-κb in female breast cancer: a study in Indian patients. Asian Pac J Cancer Prev, 13, 5511-5.
10. Jana D, Mandal S, Mukhopadhyay M, et al (2012). Prognostic significance of HER-2/neu and survival of breast cancer patients attending a specialized breast clinic in Kolkata, Eastern India. Asian Pac J Cancer Prev, 13, 3851-5.
11. Karak SG, Quatrano N, Buckley J, Ricci A Jr (2010). Prevalence and significance of perineural invasion in invasive breast carcinoma. Conn Med, 74, 17-21.
12. Khokhar A (2012). Breast cancer in India: Where do we stand and where do we go? Asian Pac J Cancer Prev, 13, 4861-6.
13. KK Ma, Wai Wang Chau, Connie HN Wong, et al (2012). Triple negative status is a poor prognostic indicator in chinese women with breast cancer: a ten year review. Asian Pac J Cancer Prev, 13, 2109-14.
14. Laguens G, Coronato S, Di Girolamo (2006). Biomarkers in breast cancer. CEJ Med, 1, 330-47.
15. Lee AH (2005). Why is carcinoma of the breast more frequent in the upper outer quadrant? a case series based on needle core biopsy diagnoses. Breast, 14, 151-2.
16. Michaelson JS, Silverstein PM, Wyatt J, et al (2002). Predicting the survival of patients with breast carcinoma using tumor size. Cancer, 95, 713-23.
17. Muhammadnejad S, Muhammadnejad A, Haddadi M, et al (2013). Correlation of microvessel density with nuclear pleomorphism, mitotic count and vascular invasion in breast and prostate cancers at preclinical and clinical levels. Asian Pac J Cancer Prev, 14, 63-8.
18. Nathanson SD, Zarbo RJ, Wachna DL, et al (2000). Microvessels that predict axillary lymph node metastases in patients with breast cancer. Arch Surg, 135, 586-93.
19. Noel W, Joseph PS, Willian RW, Judah F (1991). Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med, 324, 1-8.
20. Sarkar DK, Jana D, P. S. Patil, et al (2013). Role of NF-κB as a prognostic marker in breast cancer: a pilot study in Indian patients. Indian J Surg Oncol, 13, 0234-8.
21. Schnitt SJ (2001). Traditional and newer pathologic factors. J Natl Cancer Inst, 30, 22-6.
22. Sebastian FS, Guenther B, Aumayr K, et al (2004). Prognostic value of lymphangiogenesis and lymphovascular invasion in invasive breast cancer. Ann Surg, 240, 306-12.
23. Sen U, Sankaranarayanan R, Mandal S, et al (2002). Cancer patterns in eastern India: The first report of the Kolkata cancer registry. Int J Cancer, 100, 86-91.
24. Tan LGL, Tan YY, Heng D, Chan MY (2005). Predictors of axillary lymph node metastases in women with early breast cancer in Singapore. Singapore Med J, 46, 693-7.
25. Thames HD, Buchholz TA, Smith CD (1999). Frequency of first metastatic events in breast cancer: implications for sequencing of systemic and local-regional treatment. J Clin Oncol, 17, 2649-58.
26. Widodo I, Ferronika P, Harijadi A, et al (2013). Clinicopathological signifcance of lymphangiogenesis and tumor lymphovascular invasion in Indonesian breast cancers. Asian Pac J Cancer Prev, 14, 997-1001.